Kinder Chemo Approach Boosts Survival in Child ALL

by | Apr 30, 2026 | Health

Spread the love
A GOSH-led trial found that replacing intensive chemotherapy with blinatumomab in relapsed childhood ALL eliminated treatment-related deaths while maintaining survival rates.
Press Association

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments